identified that two CpG islands exist on the Cps1 promoter, and they are hypermethylated in patients with nonalcoholic steatohepatitis, causing a reduction in Cps1 transcription [13]. This evidence concerns the gene CPS1 and metabolic dysfunction-associated steatohepatitis.